Results 11 to 20 of about 83,665 (235)
The Lancet, 2005 Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral). Symptomatic disease is subacute or chronic and diverse in presentation and outcome.
Henry W, Murray +3 more
openaire +3 more sources
Spiny Hyperkeratosis-Like Follicular Mycosis Fungoides: A Case Report [PDF]
Middle East Journal of Cancer, 2023 Folliculotropic mycosis fungoides (FMF) is a rare variant of cutaneous T-cell lymphoma which is categorized as a separate entity. In histopathology, malignant lymphocytes selectively surround and infiltrate hair follicles.
Shatila Torabi +3 more
doaj +1 more source
Clinical Medicine, 2011 Leishmaniasis is an uncommon infectious disease in the UK with a variety of clinical presentations. Physicians should remember to consider this diagnosis in patients with an appropriate travel history (including the Mediterranean basin) and seek help with diagnostics from a specialised parasitology laboratory.
Elinor M, Moore, Diana N, Lockwood
openaire +5 more sources
Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran [PDF]
Journal of Kerman University of Medical Sciences, 2023 Background: Systemic or topical form of pentavalent antimony compounds such as Meglumine Antimoniate (MA) are used as Standard treatment for cutaneous leishmaniasis (CL).
Yalda Nahidi +5 more
doaj +1 more source
Interspecies and Intrastrain Interplay among Leishmania spp. Parasites
Microorganisms, 2022 Leishmania parasites present astonishing adaptative abilities that represent a matter of life or death within disparate environments during the heteroxenous parasite life cycle.
Bruna Dias das Chagas +6 more
doaj +1 more source
Leishmania (Viannia) naiffi Lainson & Shaw 1989
Parasites & Vectors, 2023 Just over 30 years ago, a new species of Leishmania of the subgenus Leishmania (Viannia) was described infecting the armadillo Dasypus novemcinctus; then, a report of human infection followed.
Lilian Motta Cantanhêde +1 more
doaj +1 more source
Frontiers in Microbiology, 2021 Cutaneous leishmaniasis (CL) is a curable disease; however, due to various risk factors, unresponsiveness to CL treatments is inevitable. The treatment of CL has been firmly correlated with multiple determinants, such as demographical, clinical, and ...
Mehdi Bamorovat +4 more
doaj +1 more source
Tidsskrift for Den norske legeforening, 2021 Leishmaniasis is a rare but potentially severe tropical infectious disease, and Norwegian clinicians are generally unfamiliar with its diagnosis and treatment. This study aimed to investigate the number of cases diagnosed, performance of diagnostic methods and treatment of leishmaniasis at five university hospitals in Norway.The number of cases ...
Kristine Mørch +9 more
openaire +2 more sources
Postgraduate Medical Journal, 2006 Abstract Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity
Tonio V, Piscopo +1 more
openaire +4 more sources